
无数据
无数据
无数据
| CAS Number | 95233-18-4 |
| Catalog Number | AG0036UM(AGN-PC-0W4TYJ) |
| Chemical Name | 2-(trans-4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthalenedione |
| IUPAC Name | 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione |
| InChI | InChI=1S/C22H19ClO3/c23-16-11-9-14(10-12-16)13-5-7-15(8-6-13)19-20(24)17-3-1-2-4-18(17)21(25)22(19)26/h1-4,9-13,15,24H,5-8H2 |
| InChI Key | BSJMWHQBCZFXBR-UHFFFAOYSA-N |
| MDL Number | MFCD00889188 |
| Molecular Formula | C22H19ClO3 |
| Molecular Weight | 366.8375 |
| NSC Number | 759582 |
| SMILES | ClC1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)C=1C(C2=CC=CC=C2C(C1O)=O)=O |
| UNII | Y883P1Z2LT |
| Synonyms | 2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone,
2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone,
566C,
566C80,
566C80 hydroxynaphthoquinone,
Atovaquone,
compound 566,
hydroxynaphthoquinone 566C80,
hydroxynaphthoquinone, 566C80,
Mepron,
Wellvone,
ATOVAQUONE,
95233-18-4,
Mepron,
Wellvone,
Acuvel,
Atavaquone,
566C80,
Mepron (antipneumocystic),
BW 566C,
566C,
Atovaquone (Atavaquone),
DRG-0084,
94015-53-9,
UNII-Y883P1Z2LT,
C22H19ClO3,
BW 566C-80,
HSDB 7083,
2-(trans-4-(p-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone,
137732-39-9,
BW-566C-80,
2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone,
Y883P1Z2LT,
BW-566C,
CHEBI:575568,
KUCQYCKVKVOKAY-UHFFFAOYSA-N,
2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione,
2-(TRANS-4-(4-CHLOROPHENYL)CYCLOHEXYL)-3-HYDROXY-1,4-NAPHTHALENEDIONE,
NCGC00016961-01,
2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone,
3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione,
CAS-95233-18-4,
2-[trans-4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione,
DSSTox_CID_2629,
trans-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione,
2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-dihydronaphthalene-1,4-dione,
DSSTox_RID_76664,
DSSTox_GSID_22629,
cis-Atovaquone,
2-[trans-4-(p-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone,
3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxy-naphthalene-1,2-dione,
1,4-Naphthalenedione, 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-, trans-,
1,4-Naphthalenedione, 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-,
1,4-Naphthalenedione, 2-[cis-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-,
2-((1r,4r)-4-(4-chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione,
Atovaquone [USAN:BAN:INN],
Mepron (TN),
BW-A 566C,
SR-05000001438,
CRL-8131 & Atovaquone,
2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone,
Atovaquone & Interleukin 12,
2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-naphthalene-1,4-dione,
2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione,
2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione,
ATO & IL-12,
Atovaquone [USAN:USP:INN:BAN],
atovaquone-atavaquone,
BW 566C80,
ATOVAQUONE-D4,
Spectrum_001743,
SpecPlus_000686,
AC1L2MZG,
Prestwick0_000534,
Prestwick1_000534,
Prestwick2_000534,
Prestwick3_000534,
Spectrum2_001665,
Spectrum3_000991,
Spectrum4_001117,
Spectrum5_001382,
Atovaquone EP Impurity B,
AC1Q6E9K,
SCHEMBL21694,
SCHEMBL21695,
Atovaquone (JAN/USP/INN),
BSPBio_000547,
BSPBio_002681,
KBioGR_001594,
KBioSS_002223,
MLS002153863,
BIDD:GT0849,
DivK1c_006782,
SCHEMBL637069,
SPECTRUM1504210,
SPBio_001849,
SPBio_002468,
BPBio1_000603,
CHEMBL222334,
CHEMBL519462,
GTPL9695,
NAP016,
SCHEMBL1542719,
SCHEMBL1649508,
SCHEMBL9975142,
SCHEMBL9975229,
Atovaquone, >=98% (HPLC),
DTXSID7022629,
CHEBI:95346,
CTK5H7581,
KBio1_001726,
KBio2_002223,
KBio2_004791,
KBio2_007359,
KBio3_001901,
KUCQYCKVKVOKAY-CTYIDZIISA-N,
KUCQYCKVKVOKAY-OTVXOJSOSA-N,
BDBM192009,
HMS1569L09,
HMS1922F19,
HMS2089M14,
HMS2093C10,
HMS2096L09,
HMS2235N08,
HMS3369N09,
HMS3651N20,
HMS3713L09,
Pharmakon1600-01504210,
BCP09477,
KS-00000FO3,
Tox21_110714,
CCG-39090,
FD7252,
MFCD00889188,
NSC759582,
s3079,
STK636160,
trans-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone,
ZINC12504271,
AKOS005567953,
AKOS015895691,
AKOS015961933,
Tox21_110714_1,
ZINC100017856,
ZINC100345537,
ZINC116473771,
ZINC299873031,
AN-6439,
BW-556C-80,
CCG-220534,
CS-2702,
DB01117,
MCULE-7318126574,
NSC-759582,
NCGC00016961-02,
NCGC00016961-03,
NCGC00016961-04,
NCGC00016961-06,
NCGC00016961-07,
NCGC00095113-01,
NCGC00095113-02,
AC-30251,
AK544285,
AS-12809,
BC208879,
HY-13832,
SC-15688,
SC-21393,
SMR001233220,
SBI-0052893.P002,
AB0012456,
AB0107187,
AB0211463,
LS-178256,
TX-010638,
AB00513855,
FT-0081084,
FT-0602868,
SW219222-1,
A13708,
C06835,
D00236,
J90007,
78668-EP2307343A1,
AB00053222-03,
AB00053222_04,
AB00053222_05,
233A184,
I06-0872,
SR-05000001438-1,
SR-05000001438-2,
SR-05000001438-4,
SR-05000001438-5,
2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-nap,
Z1541632806,
2-[4-(4-chlorophenyl)cyclohexy]-3-hydroxy-1,4-naphthoquinone,
2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-napthoquinone,
2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1.4-naphthoquinone,
2-Hydroxy-3-[4-(4-chlorophenyl)cyclohexyl]-1,4-naphthoquinone,
3-[4-(p-chlorophenyl)cyclohexyl]-4-hydroxy-1,2-naphthoquinone,
1,4-Naphthalenedione, 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-,
2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxynaphthoquinone, trans-,
3-[4-(4-Chlorophenyl)cyclohexyl]-4-hydroxy-1,2-naphthalenedione,
Cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone,
1,4-Naphthalenedione, 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy,
1,4-naphthalenedione,2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-,
Malarone,
Malarone Pediatric,
pron,
Mixture Name,
Compound 566,
Malarone (Salt/Mix),
Atovaquone (USP/INN),
566C80 hydroxynaphthoquinone,
D06ZEE,
hydroxynaphthoquinone 566C80,
CHEMBL1450,
hydroxynaphthoquinone, 566C80,
Atovaquone [USAN:INN:BAN],
566C80, hydroxynaphthoquinone,
atovaquone GlaxoSmithKline brand,
Atovaquone, 98% - 1G 1g,
C22-H19-Cl-O3,
Glaxo Wellcome brand of atovaquone,
GlaxoSmithKline brand of atovaquone,
CID74989,
AR-1H7607,
BW 556C-80,
CS-O-00850,
A2545,
B2078,
D053626,
2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone,
2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone,
3-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxy-naphthalene-1,2-dione,
2-[4-(4-chlorophenyl)-cyclohexyl]-3-hydroxy-1,4-naphthoquinone,
996-42-9,
ATQ,
|
| Complexity | 595 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 366.102g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 26 |
| Hydrogen Bond Acceptor Count | 3 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 366.841g/mol |
| Monoisotopic Mass | 366.102g/mol |
| Rotatable Bond Count | 2 |
| Topological Polar Surface Area | 54.4A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 5.2 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code | \N |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

